Apoptotic effects of the tyrosine kinase inhibitor, masitinib mesylate, on canine osteosarcoma cells
Tools
Tools
Tools
Fahey, CE, Milner, RJ, Kow, K, Bacon, NJ and Salute, ME (2013) Apoptotic effects of the tyrosine kinase inhibitor, masitinib mesylate, on canine osteosarcoma cells ANTI-CANCER DRUGS, 24 (5). pp. 519-526.
Full text not available from this repository.| Item Type: | Article | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Divisions : | Surrey research (other units) | ||||||||||||||||||
| Authors : |
|
||||||||||||||||||
| Date : | 1 June 2013 | ||||||||||||||||||
| DOI : | 10.1097/CAD.0b013e32836002ba | ||||||||||||||||||
| Uncontrolled Keywords : | Science & Technology, Life Sciences & Biomedicine, Oncology, Pharmacology & Pharmacy, ONCOLOGY, PHARMACOLOGY & PHARMACY, canine osteosarcoma, comparative oncology, masitinib mesylate, tyrosine kinase inhibitor, DOXORUBICIN COMBINATION CHEMOTHERAPY, SIGNAL-TRANSDUCTION INHIBITION, APPENDICULAR OSTEOSARCOMA, GROWTH-FACTOR, IN-VITRO, OSTEO-SARCOMA, NUDE-MICE, DOGS, AMPUTATION, CISPLATIN | ||||||||||||||||||
| Related URLs : | |||||||||||||||||||
| Depositing User : | Symplectic Elements | ||||||||||||||||||
| Date Deposited : | 17 May 2017 10:19 | ||||||||||||||||||
| Last Modified : | 24 Jan 2020 18:59 | ||||||||||||||||||
| URI: | http://epubs.surrey.ac.uk/id/eprint/827305 |
Actions (login required)
 |
View Item |
Downloads
Downloads per month over past year